RELMADA THERAPEUTICS, INC. Common Stock Shares Outstanding

Quick Answer

RELMADA THERAPEUTICS, INC. reported Common Stock Shares Outstanding of 73.33 million shares for the year ending 2025.

  • RELMADA THERAPEUTICS, INC. showed an increase of +143.0% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from RELMADA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2014 to 2025), RELMADA THERAPEUTICS, INC.'s Common Stock Shares Outstanding has grown by 810.0%.
  • Historical annual values: Fiscal year 2025: 73.33 million shares | Fiscal year 2024: 30.17 million shares | Fiscal year 2023: 30.10 million shares | Fiscal year 2022: 30.10 million shares | Fiscal year 2021: 27.74 million shares | Fiscal year 2020: 16.33 million shares | Fiscal year 2019: 14.46 million shares | Fiscal year 2019: 9.74 million shares | Fiscal year 2018: 12.55 million shares | Fiscal year 2017: 12.53 million shares | Fiscal year 2016: 12.04 million shares | Fiscal year 2015: 10.78 million shares | Fiscal year 2014: 8.06 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: